n(6)-carboxymethyllysine has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alscher, D; Brenner, S; Butscheid, M; Frischmann, M; Klotz, U; Mürdter, T; Niwa, T; Pischetsrieder, M; Schäfer, C | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Hepatitis C
| Article | Year |
|---|---|
Unchanged serum levels of advanced glycation endproducts in patients with liver disease.
Topics: Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Glycation End Products, Advanced; Hepatitis C; Humans; Imidazoles; Lysine; Male; Middle Aged; Renal Insufficiency | 2007 |